WithdrawnNCT02213887
Study of the Effects of Pantoprazole on Levels of Prescribed Psychiatric Medications
Medication studyAges 19–65CanadaSchizophrenia
Understand this study
Who could participate?
Listed age limits: 19 years to 65 years.
- Listed locations
- VancouverSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateSeptember 2014
- Recruitment status
- Withdrawn
- Enrollment listed in the registry
- 0
- Sponsor
- University of British Columbia
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- Canada
- Age range
- From 19 Years to 65 Years
- Official registry ID
- NCT02213887
- Official title
Show the full official title
A Pilot Study to Determine if Pantoprazole Modifies Steady-State Plasma Concentrations of Orally Administered Psychotropic Medications
Recruitment & locations
WithdrawnThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Vancouver
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of British Columbia, a university.
Does this study involve medication?
Yes. The study involves medication, including Pantoprazole.
Who can participate?
Listed age limits: 19 years to 65 years.
Is this study still recruiting?
The registry lists this study as withdrawn.
